|
Volumn 18, Issue 14, 2010, Pages 5039-5047
|
Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy
|
Author keywords
DABPs; HIV 1 Reverse transcriptase; Molecular hybridization; NNRTIs; SAR
|
Indexed keywords
3 CHLORO 4 [2 (4 CYANOPHENYLAMINO)QUINAZOLIN 4 YLOXY] 5 METHOXYBENZONITRILE;
4 [2 (4 CYANOPHENYLAMINO)QUINAZOLIN 4 YLOXY] 3,5 DIMETHYLBENZONITRILE;
6 CHLORO 4 (2 CYCLOPROPYLVINYL) 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
BENZENE DERIVATIVE;
DELAVIRDINE;
EFAVIRENZ;
ETRAVIRINE;
NEVIRAPINE;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
ARTICLE;
DRUG POTENCY;
DRUG SELECTIVITY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HYBRID;
MOLECULAR HYBRIDIZATION;
NONHUMAN;
STEREOCHEMISTRY;
VIRUS MUTANT;
VIRUS STRAIN;
WILD TYPE;
ANTI-HIV AGENTS;
CELL LINE;
CELL SURVIVAL;
HIV INFECTIONS;
HIV REVERSE TRANSCRIPTASE;
HIV-1;
HUMANS;
MODELS, MOLECULAR;
PROTEIN BINDING;
PYRIDAZINES;
QUINAZOLINES;
REVERSE TRANSCRIPTASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 77955316010
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.05.081 Document Type: Article |
Times cited : (38)
|
References (21)
|